Results 201 to 210 of about 33,686 (303)

Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial

open access: yesInternational Journal of Cancer, EarlyView.
Antiangiogenic treatment with ramucirumab is a standard second‐line option in advanced gastric and gastroesophageal junction adenocarcinoma. However, reliable biomarkers are currently lacking. This exploratory biomarker analysis of the RAMIRIS trial suggests that elevated baseline and early on‐treatment levels of the pro‐angiogenic placental growth ...
Jurek Hille   +17 more
wiley   +1 more source

Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort

open access: yesInternational Journal of Cancer, EarlyView.
The immune system has been implicated as a major driver in pancreatic cancer etiology. Previous cohort studies have found associations between pancreatic cancer and single immune system‐derived markers, but omics‐based evidence remains scarce. In this prospective case–control study, the authors investigated 92 proteins involved in immune reactions and ...
Verena A. Katzke   +28 more
wiley   +1 more source

Evaluation of six eco-analytical tools for the sustainable HPLC analysis of a quinary anti-cold drug mixture. [PDF]

open access: yesSci Rep
Al-Wasidi AS   +5 more
europepmc   +1 more source

Evaluating predictive values of umbilical cord arterial lactate for adverse newborn outcomes among term‐births in northern Uganda: A cross sectional analytical study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 408-420, April 2025.
Abstract Objective Birth asphyxia is one of the leading causes of death for neonates worldwide. Lack of an objective cost effective test to predict poor newborn outcomes at birth affects the ability to respond appropriately. This study determined predictive values of umbilical cord arterial lactate in relation to adverse neonatal outcomes. Methods This
Elizabeth Ayebare   +7 more
wiley   +1 more source

Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score. [PDF]

open access: yesAppl Immunohistochem Mol Morphol
He M   +14 more
europepmc   +1 more source

Computational Intelligence Accelerates CRISPR‐Cas‐Based Diagnostic Design

open access: yesiLABMED, EarlyView.
Computational intelligence, including pangenome‐guided target mining, machine‐learning‐based guide RNA optimization, and autonomous AI agents, is shifting CRISPR diagnostic design from empirical screening to systematic, data‐driven engineering and accelerating the path from pathogen discovery to deployable diagnostics.
Hengyu Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy